Swept-source OCT better for imaging posterior sclera, not lamina cribrosa

Article

Swept-source optical coherence tomography (OCT) may be superior to enhanced depth imaging (EDI)-OCT in imaging the posterior sclera, but not in imaging the lamina cribrosa, according to a study published online in the American Journal of Ophthalmology.

Swept-source optical coherence tomography (OCT) may be superior to enhanced depth imaging (EDI)-OCT in imaging the posterior sclera, but not in imaging the lamina cribrosa, according to a study published on-line in the American Journal of Ophthalmology.

Researchers from The Catholic University of Korea, Seoul, obtained both EDI-OCT and swept-source OCT images in 32 myopic patients with glaucoma. B-scan images were used to obtain subfoveal choroidal, subfoveal scleral, and central laminar thicknesses, performed at three locations by two masked observers.

With EDI-OCT, the posterior border of the sclera was visible in 31% of eyes, compared with 53% using swept-source OCT. Using McNemar's Χ2-test, detection of the posterior border of the sclera was significantly different between the two imaging modalities (P = 0.008), while that of the posterior border of the lamina cribrosa was similar. In highly myopic eyes, the detection rate of the posterior border of the sclera and lamina cribrosa was not significantly different. Intersystem intraclass correlation coefficient (ICC) was 0.769 for subfoveal scleral thickness and 0.900 for laminar thickness. Mean subfoveal scleral thickness was 464.32 μm with EDI-OCT, compared with 650.26 μm with swept-source OCT, a statistically significant difference (P = 0.018).

To view a copy of the abstract, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.